Results 61 to 70 of about 1,718 (131)

Spinal pain: causes and treatment policy

open access: yesСовременная ревматология, 2018
Chronic pain in the spine is one of the most urgent medical problems. Clinical and instrumental studies fail to reveal that most patients with back pain have any structural changes that may contribute to its occurrence. It is considered that the pain may
Yu. A. Olyunin
doaj   +1 more source

SYMPTOMATIC THERAPY FOR PAIN IN RHEUMATIC DISEASES: A PLACE OF ACECLOFENAC

open access: yesСовременная ревматология, 2009
Nonsteroidal anti-inflammatory drugs (NSAID) are prominent among the analgesics used in rheumatology. The effects of aceclofenac are described in rheumatic diseases.
V A Nasonova   +1 more
doaj   +1 more source

Ведение пациентов с болевыми синдромами на фоне COVID-19

open access: yesНеврология, нейропсихиатрия, психосоматика, 2020
The disease caused by COVID-19 is multi-organ and involves almost all organs and systems. Myalgias and arthralgias and back pain are common symptoms of COVID-19 and can be observed both at the onset of the disease and in the postcoid period. The cause of
L. Т. Аkhmedzhanova   +2 more
doaj  

Aceclofenac loaded microspheres: Formulation and evaluation of novel preprogrammed drug delivery for the treatment of arthritis

open access: yesIntelligent Pharmacy
Arthritis is a widespread joint disorder globally, the patient completely dependent on NSAIDs which are administered after a fixed interval to subside the pain.
Hema Jaiswal   +5 more
doaj   +1 more source

Aceclofenac: therapeutic effectiveness in osteoarthrosis

open access: yesСовременная ревматология, 2010
The place of aceclofenac in a group of nonsteroidal anti-inflammatory drugs and its efficacy in osteoarthrosis are discussed.
Tatyana Alekseyevna Raskina
doaj  

Home - About - Disclaimer - Privacy